NCCN 2012 Congress Series: Genitourinary Cancers™

Nashville, TN US
July 20, 2012

This congress is a full-day educational program designed to provide an in-depth analysis of the evidence and clinical decision-making that led to the development of the NCCN Guidelines® for Bladder, Kidney, and Prostate Cancers. Participants will learn how to implement the NCCN Guidelines recommendations into their practice and gain a clear understanding of the most up-to-date treatment recommendations for these cancers. As research continues in these areas and new information emerges, it is critical that clinicians are kept up-to-date and informed. This congress will communicate the NCCN Guidelines in a direct and interactive way to community oncologists and other clinical professionals.

Target Audience

This educational program is designed to meet the educational needs of oncologists, pathologists, nurses, pharmacists, and other health care professionals who manage patients with cancer.

Learning Objectives

Following this congress, participants should be able to:

Kidney Cancer

  • Summarize the role of surgical management in localized and resectable advanced kidney cancer
  • Apply existing and emerging clinical research data to make evidence-based selection of front-line and subsequent therapy for advanced renal cell cancer

Bladder Cancer

  • Recognize the role of adjuvant intravesical therapy in non-invasive bladder cancer management
  • Describe the role of chemotherapy and radiation therapy in the treatment of invasive bladder cancer
  • Summarize the role of bladder preservation in the management of invasive bladder cancer
  • Apply existing and emerging clinical research data to make evidence-based selection of front-line and subsequent therapy for treatment of bladder cancer to maintain the best possible quality of life

Prostate Cancer

  • Counsel patients with localized prostate cancer on the appropriate therapeutic options based on individual risk assessment
  • Describe novel agents approved for advanced disease
  • Outline patient selection criteria for the proper use of novel agents in advanced disease
  • Outline the use and benefits of radiation therapy in various disease settings
Additional information
Supporters: 

This activity is supported an independent educational grant from:

  • Abbott

This activity is supported by an educational donation provided by:

  • Amgen

This activity is supported by educational grants from:

  • Astellas
  • Pfizer
  • sanofi-aventis U.S.
Course summary
Available credit: 
  • 5.50 Participation
  • 5.42 Nurse
  • 5.50 Pharmacist
  • 5.50 Physician
Course opens: 
07/20/2012
Course expires: 
12/31/2012
Event starts: 
07/20/2012 - 8:00am
Event ends: 
07/20/2012 - 3:15pm
Cost:
$0.00
Gaylord Springs Golf Links
18 Springhouse Lane
(Clubhouse - 2nd Floor)
Nashville, TN 37214
United States

Agenda

7:15 – 8:00 AM
Registration, Breakfast, and Exhibits

8:00 – 8:10 AM
Welcome
Peter E. Clark, MD
Vanderbilt-Ingram Cancer Center

KIDNEY CANCER

8:10 – 8:55 AM
Surgical Management of Localized Kidney Cancer and Resectable Advanced Disease
Sam S. Chang, MD
Vanderbilt-Ingram Cancer Center

9:00 – 9:45 AM
Targeted Therapy Options in Unresectable and Recurrent Kidney Cancer
Toni K. Choueiri, MD
Dana-Farber/Brigham and Women's Cancer Center

9:45 – 10:05 AM
Break and Exhibits

BLADDER CANCER

10:05 – 11:00 AM
Treatment of Non-Metastatic Bladder Cancer
Peter E. Clark, MD
Vanderbilt-Ingram Cancer Center

11:05 – 11:50 AM
Treatment of Advanced Bladder Cancer 
Lance C. Pagliaro, MD
The University of Texas MD Anderson Cancer Center

11:50 AM – 12:50 PM
Lunch and Exhibits

PROSTATE CANCER

12:50 – 1:35 PM
Risk Assessment for Locoregional Prostate Cancer
James L. Mohler, MD
Roswell Park Cancer Institute

1:40 – 2:25 PM
Treatment of Advanced Prostate Cancer
Sandy Srinivas, MD
Stanford Cancer Institute

2:30 – 3:15 PM
Radiation Therapy in Prostate Cancer
Michael Kuettel, MD, MBA, PhD
Roswell Park Cancer Institute

3:15 PM
Closing Remarks

This Congress is approved for AMA PRA Category 1 Credit(s)™. Nursing and pharmacy (ACPE) credits are also provided for all sessions. Please view the complete accreditation details for additional information.

Available Credit

  • 5.50 Participation
  • 5.42 Nurse
  • 5.50 Pharmacist
  • 5.50 Physician

Accreditation Period

Course opens: 
07/20/2012
Course expires: 
12/31/2012

Price

Cost:
$0.00
Please login or register to take this course.